-
公开(公告)号:NO164771B
公开(公告)日:1990-08-06
申请号:NO844778
申请日:1984-11-30
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , SPIEGLER WOLFGANG , SIEGEL HARDO , MUELLER CLAUS D , PHILIPSBORN GERDA VON , LENKE DIETER , GRIES JOSEF
IPC: A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/495 , A61P9/06 , C07D207/32 , C07D207/333 , C07D213/50 , C07D231/12 , C07D307/46 , C07D333/22 , C07D409/12
-
公开(公告)号:FI77224C
公开(公告)日:1989-02-10
申请号:FI823217
申请日:1982-09-17
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , MUELLER JOSEF , LIETZ HELMUT , WIERSDORFF WALTER-WIELANT , HEGE HANS-GUENTHER , MUELLER CLAUS D , GRIES JOSEF , LENKE DIETER , VON PHILIPSBORN GERDA , RASCHACK MANFRED
IPC: A61K31/13 , A61K31/445 , A61K31/495 , C07C45/62 , C07C45/71 , C07C45/73 , C07C45/74 , C07C49/83 , C07C49/835 , C07C49/84 , C07D211/46 , C07D211/52 , C07D295/08 , C07D295/092 , C07D303/22 , C07D303/24 , C07C93/06 , C07C93/14 , C07C97/10 , C07C149/24 , C07D207/06 , C07D207/12 , C07D211/14 , C07D211/40
-
公开(公告)号:FI71146C
公开(公告)日:1986-11-24
申请号:FI820529
申请日:1982-02-17
Applicant: BASF AG
Inventor: BINNIG FRITZ , MUELLER CLAUS D , RASCHACK MANFRED , PHILIPSBORN GERDA VON
IPC: A61K31/435 , A61K31/445 , A61P9/00 , A61P9/06 , C07D221/00 , C07D471/08
Abstract: Bispidine derivatives of the formula I I where R is hydrogen or amino, and their salts with physiologically tolerated acids. The compounds have antiarrhythmic properties.
-
公开(公告)号:FI70013B
公开(公告)日:1986-01-31
申请号:FI802960
申请日:1980-09-19
Applicant: BASF AG
Inventor: FRICKEL FRITZ-FRIEDER , FRANKE ALBRECHT , PHILIPSBORN GERDA VON , MUELLER CLAUS D , LENKE DIETER
IPC: A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4427 , A61K31/445 , A61K31/454 , A61K31/47 , A61P9/00 , A61P9/06 , C07C271/22 , C07D207/34 , C07D207/36 , C07D209/42 , C07D401/12 , C07D401/14
Abstract: Substituted piperidinoalkyl ethers of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters and their physiologically tolerated addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
公开(公告)号:CS238621B2
公开(公告)日:1985-12-16
申请号:CS245882
申请日:1982-04-06
Applicant: BASF AG
Inventor: EHRMANN OSKAR , RASCHACK MANFRED , GRIES JOSEF , KRETZSCHMAR ROLF , LEHMAN HANS D , FRIEDRICH LUDWIG , WUPPERMANN DIRK , ZIMMERMANN FRANK , SEITZ WERNER , TREIBER HANS J , DENGEL FERDINAND , FRANK WOLFRAM , KURBJUWEIT HANS-GEORG , MUELLER CLAUS D
IPC: C07C255/42 , A61K31/275 , A61K31/277 , A61K31/335 , A61P9/06 , A61P9/10 , A61P37/08 , C07C253/30 , C07C255/32 , C07C255/53 , C07C255/58 , C07D317/06 , C07D317/58 , C07D317/60 , C07D319/02 , C07D319/08 , C07D319/18 , C07C121/66
-
公开(公告)号:ZA849380B
公开(公告)日:1985-08-28
申请号:ZA849380
申请日:1984-12-03
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , SPIEGLER WOLFGANG , SIEGEL HARDO , MUELLER CLAUS D , PHILIPSBORN GERDA VON , LENKE DIETER , GRIES JOSEF
IPC: A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/495 , A61P9/06 , C07D207/32 , C07D207/333 , C07D213/50 , C07D231/12 , C07D307/46 , C07D333/22 , C07D409/12 , C07D , A61K
-
公开(公告)号:AU546256B2
公开(公告)日:1985-08-22
申请号:AU8196282
申请日:1982-03-26
Applicant: BASF AG
Inventor: BINNIG FRITZ , MUELLER CLAUS D , RASCHACK MANFRED , PHILIPSBORN GERDA VON
IPC: A61K31/435 , A61K31/445 , A61P9/00 , A61P9/06 , C07D221/00 , C07D471/08
Abstract: Bispidine derivatives of the formula I I where R is hydrogen or amino, and their salts with physiologically tolerated acids. The compounds have antiarrhythmic properties.
-
公开(公告)号:NO844778A
公开(公告)日:1985-06-03
申请号:NO844778
申请日:1984-11-30
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , SPIEGLER WOLFGANG , SIEGEL HARDO , MUELLER CLAUS D , PHILIPSBORN GERDA VON , LENKE DIETER , GRIES JOSEF
IPC: A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/495 , A61P9/06 , C07D207/32 , C07D207/333 , C07D213/50 , C07D231/12 , C07D307/46 , C07D333/22 , C07D409/12 , C07D
CPC classification number: C07D207/333 , C07D213/50 , C07D231/12 , C07D307/46 , C07D333/22 , C07D409/12
-
公开(公告)号:CS236500B2
公开(公告)日:1985-05-15
申请号:CS712783
申请日:1983-09-29
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , MUELLER JOSEF , LIETZ HELMUT , WIERSDORF WALTER-WIELANT , HEGE HANS-GUENTHER , MUELLER CLAUS D , GRIES JOSEF , LENKE DIETER , VON PHILIPSBORN GERDA , RASCHACK MANFRED
IPC: A61K31/135 , A61K31/395 , C07D295/08 , C07D295/10 , C07C97/10 , C07C93/06 , C07D341/12
-
80.
公开(公告)号:ZA838692B
公开(公告)日:1984-07-25
申请号:ZA838692
申请日:1983-11-22
Applicant: BASF AG
Inventor: SCHLECKER RAINER , SCHMIDT PETER , THIEME PETER C , LENKE DIETER , TESCHENDORF HANS-JUERGEN , TRAUT MARTIN , MUELLER CLAUS D , HOFMANN HANS-PETER , KREISKOTT HORST
IPC: A61K31/35 , A61K31/352 , A61K31/365 , A61K31/37 , A61P25/18 , A61P25/24 , A61P25/26 , A61P37/08 , A61P43/00 , C07D311/08 , C07D311/16 , C07D311/78 , C07D311/80 , A61K , C07D
Abstract: Sulfonates of hydroxycoumarins of the formula I (I) where R1 and R2 are identical or different and are each hydrogen, halogen or alkyl of 1 to 5 carbon atoms which can be substituted by -NR4R5, -OR4 or -OC(O)R4, where R4 and R5 are identical or different and are each hydrogen or alkyl of 1 to 4 carbon atoms, or R1 and R2 are each a carboxylic acid group -OC(O)R4 or a carboxamido radical, with the proviso that R1 is not methyl when R2 is hydrogen, or R1 and R2 together form a -(CH2)n- chain where n is 3-5, and R3 is a straight-chain or branched alkyl radical of 1 to 8 carbon atoms or cycloalkyl of 3 to 8 carbon atoms, each of which can be substituted by halogen, -OR4, -NR4R5, -CN or phenyl, or R3 is a straight-chain or branched alkenyl radical of 3 to 8 carbon atoms, an amino group - NR4R5, or phenyl or naphthyl, each of which is unsubstituted or monosubstituted or polysubstituted by -OR4, -NR4R5, -NO2, halogen, -SR4, -S(O)R4, -OS(O)R4, -SCF3, -OS(O)CF3, -CN, -C(O)R4, -OC(O)R4, -NHC(O)R4, -CF3, C1-C4-alkyl or a combination of these substituents, a process for their preparation, drugs containing these compounds, and compounds of the formula I, in which R1 is methyl and R2 is hydrogen, for use as drugs.
-
-
-
-
-
-
-
-
-